CareTrust REIT vs Omega Healthcare Investors
CTRE and OHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CTRE and OHI compare
Omega Healthcare Investors is the larger company, worth 1.7 times as much as CareTrust REIT ($14.2B against $8.6B).
On earnings, Omega Healthcare Investors is cheaper: it trades at 17.0× trailing earnings, against 22.9× for CareTrust REIT.
CareTrust REIT grew revenue faster over the last twelve months (53.0% versus 15.0% for Omega Healthcare Investors).
Omega Healthcare Investors keeps more of each dollar of sales as profit, with a net margin of 67.0% compared with 62.2% at CareTrust REIT.
Both pay dividends: CareTrust REIT yields 4.1% and Omega Healthcare Investors 5.7%.
CareTrust REIT scores higher on the StockData Score (15 against 12 for Omega Healthcare Investors), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CTRE | OHI |
|---|---|---|
| Size and price | ||
| Market cap | $8.6B | $14.2B |
| Share price | $36.39 | $46.98 |
| Change, 1 year | 7.1% | 18.8% |
| Change, 5 years | 72.5% | 57.0% |
| Beta (5Y) | 0.52 | 0.27 |
| Employees | 43 | 69 |
| StockData Score | ||
| Total score | 15 (better) | 12 |
| Valuation score | 2 | 3 (better) |
| Growth score | 4 (better) | 3 |
| Performance score | 4 (better) | 2 |
| Health score | 1 (better) | 0 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 22.9× | 17.0× (better) |
| P/S | 15.0× | 11.1× (better) |
| P/B | 1.9× (better) | 2.6× |
| EV/EBITDA | 16.2× | 10.0× (better) |
| PEG | – | 6.71 |
| Fair value | $32.95 | $52.14 |
| Margin of safety | −10.4% | 9.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 53.0% (better) | 15.0% |
| Revenue growth, 5Y average | 21.7% (better) | 5.9% |
| Net income growth (TTM) | 61.6% | 82.4% (better) |
| EPS growth (TTM) | 32.5% | 73.1% (better) |
| EPS growth, 5Y average | 13.1% | 22.6% (better) |
| Profitability | ||
| Net margin | 62.2% | 67.0% (better) |
| Return on equity | 9.1% | 16.5% (better) |
| Financial health | ||
| Altman Z-score | 3.74 (better) | 2.81 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 4.1% | 5.7% (better) |
| Payout ratio | 85.9% | 92.6% |
| Years of dividend growth | 11 (better) | 0 |
| Dividend growth, 5Y average | 6.0% (better) | 0.00% |
| Buyback yield | −13.8% | – |
| Shareholder yield | −9.7% | 5.7% (better) |
| Ownership | ||
| Held by institutions | 106% | 81.8% |
| Held by insiders | 0.99% | 0.19% |
| Insider net buying, 12 months | – | $1.4M |
| Short interest, % of float | 4.7% | 5.2% |
Go deeper
- CTRE stock overview
- CTRE income statement
- CTRE valuation and score
- OHI stock overview
- OHI income statement
- OHI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.